PLA2G1B Antikörper (C-Term)

Produktnummer ABIN374873

Produktdetails anti-PLA2G1B Antikörper

Target: PLA2G1B (Phospholipase A2, Group IB (PLA2G1B))

Bindungsspezifität: C-Term

Reaktivität: Human, Hund

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser PLA2G1B Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Sequenz: NKAHKNLDTK KYCQS

Spezifität: This antibody detects PLA2G1B at C-term.

Kreuzreaktivität (Details): Species reactivity (tested):Human, Dog

Aufreinigung: Ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide

Immunogen: Peptide from the C Terminus of the protein sequence according to NP_000919.1 Genename: PLA2G1B

Anwendungsinformationen

Applikationshinweise: Peptide ELISA: antibody detection limit dilution 1: 64000. Western blot: 0.01 μg/mL. Approx.17-18 kDa band observed in Human Pancreas lysates(calculated MW of 16.8 kDa according to NP_000919.1). In transfected HEK293 transientlyexpressing PLA2G1B a band of approx.18 kDa is observed. This band is not observed in thenon-transfected HEK293.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 0.5 mg/mL

Buffer: Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.

Details zu PLA2G1B

Target: PLA2G1B (Phospholipase A2, Group IB (PLA2G1B))

Andere Bezeichnung: PLA2G1B (PLA2G1B Produkte)

Synonyme: C133 antikoerper, CG4346 antikoerper, Dmel\\CG42237 antikoerper, Dmel_CG4346 antikoerper, PLA2 antikoerper, GB13351 antikoerper, bvPLA2 antikoerper, PLA2A antikoerper, PPLA2 antikoerper, sPLA(2)-IB antikoerper, Pla2a antikoerper, sPLA2IB antikoerper, PLA2G1B antikoerper, CG42237 gene product from transcript CG42237-RB antikoerper, phospholipase A2 antikoerper, phospholipase A2 group IB antikoerper, phospholipase A2, group IB, pancreas antikoerper, phospholipase A2 group IVA antikoerper, CG42237 antikoerper, PLA2 antikoerper, LOC100631065 antikoerper, Pla2 antikoerper, PLA2G1B antikoerper, Pla2g1b antikoerper, PLA2G4A antikoerper

Hintergrund: Phospholipase A2 (EC 3.1.1.4) catalyzes the release of fatty acids from glycero-3-phosphocholines. The best known varieties are the digestive enzymes secreted as zymogens by the pancreas of mammals. Sequences of pancreatic PLA2 enzymes from a variety of mammals have been reported. One striking feature of these enzymes is their close homology to venom phospholipases of snakes. Other forms of PLA2 have been isolated from brain, liver, lung, spleen, intestine, macrophages, leukocytes, erythrocytes, inflammatory exudates, chondrocytes, and platelets (Seilhamer et al., 1986 [PubMed 3028739]).Synonyms: Group IB phospholipase A2, PLA2, PLA2A, PLA2G1B, PPLA2, Phosphatidylcholine 2-acylhydrolase 1B, Phospholipase A2

Gen-ID: 5319, 9606

UniProt: P04054

Pathways: Inositol Metabolic Process, VEGF Signaling